Heyholder
‹ Activism Filings

IntoCell, Inc. Q3 operating loss of KRW 3.6 billion on revenue of KRW 53.9 million

IntoCell, Inc.· Periodic Report

AI summary · Not investment advice

Intocell sold KRW 53.9 million in Q3 and lost KRW 3.6 billion from its main business; sales fell 96.2% from a year earlier and 92.9% from the prior quarter.

Operating profit · 3 months

KRW -3.6 billion

Key facts

Revenue (3 months)
KRW 53.9 million
Net income (3 months)
KRW -3.5 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 1.4 billion
Revenue (year to date)
KRW 1.1 billion
Operating profit (prior-year 3 months)
KRW -1.3 billion
Operating profit (year to date)
KRW -9.3 billion
Net income (prior-year 3 months)
KRW -1.1 billion
Net income (year to date)
KRW -9.6 billion

Commentary

AI commentary · Not investment advice

What happened

Intocell filed its quarterly report for Q3 2026 on a standalone basis. Sales for the latest 3 months were KRW 53.9 million. In the same 3 months a year earlier, sales were KRW 1.42 billion. Sales for the year to date were KRW 1.10 billion.

In the company's terms

Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 3.60 billion. A year earlier, the same 3 months showed a loss of KRW 1.30 billion. The year-to-date operating loss was KRW 9.34 billion.

What changes for shareholders

Net income (the final profit after taxes and all other items) for the latest 3 months was a loss of KRW 3.49 billion. A year earlier, the same 3 months showed a loss of KRW 1.14 billion. The year-to-date net loss was KRW 9.57 billion.

Sales for the latest 3 months fell 96.2% from the same period a year earlier. They fell 92.9% from the previous quarter.

Comments

No comments yet

Comments from shareholders will appear here.